Format

Send to

Choose Destination
Ophthalmology. 2018 Jun;125(6):945-947. doi: 10.1016/j.ophtha.2017.12.036. Epub 2018 Feb 14.

Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy.

Author information

1
Centre d'Investigation Clinique 1423, Inserm-DGOS, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France; Rothschild Ophthalmology Foundation Hospital, Paris, France.
2
GenSight Biologics, Paris, France.
3
Centre d'Investigation Clinique 1423, Inserm-DGOS, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France.
4
GenSight Biologics, Paris, France; GenSight Biologics Inc., New York, New York. Electronic address: bkatz@gensight-biologics.com.
5
Centre d'Investigation Clinique 1423, Inserm-DGOS, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France; Rothschild Ophthalmology Foundation Hospital, Paris, France; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France; Department of Ophthalmology, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
PMID:
29426586
DOI:
10.1016/j.ophtha.2017.12.036
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center